Please use this identifier to cite or link to this item:
|Title:||TIPICO XI: report of the first series and podcast on infectious diseases and vaccines (aTIPICO)|
Pollard, Andrew J.
Ladhani, Shamez N.
Gómez Rial, Jose
Bosch, F. Xavier
Mina, Michael J.
|Keywords:||Infectious disease;vaccinepreventable disease;COVID- 19 pandemic;control of transmission;vaccineimmunity response;severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)|
|Publisher:||Taylor and Francis Ltd.|
|Citation:||Human Vaccines & Immunotherapeutics, 17:11, 4299-4327|
|Abstract:||TIPiCO is an annual expert meeting and workshop on infectious diseases and vaccination. The edition of 2020 changed its name and format to aTIPiCO, the first series and podcasts on infectious diseases and vaccines. A total of 13 prestigious experts from different countries participated in this edition launched on the 26 November 2020. The state of the art of coronavirus disease-2019 (COVID-19) and the responsible pathogen, the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), and the options to tackle the pandemic situation were discussed in light of the knowledge in November 2020. Despite COVID-19, the status of other infectious diseases, including influenza infections, respiratory syncytial virus disease, human papillomavirus infection, measles, pertussis, tuberculosis, meningococcal disease, and pneumococcal disease, were also addressed. The essential lessons that can be learned from these diseases and their vaccines to use in the COVID-19 pandemic were also commented with the experts.|
|Appears in Collections:||Paleobiología|
Files in This Item:
|TIPICO XI report of the first series and podcast on infectious diseases and vaccines aTIPICO_Martinón-Torres_et_al_2021.pdf||1.08 MB||Adobe PDF|
This item is licensed under a Creative Commons License